Status:
UNKNOWN
Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment
Lead Sponsor:
Gail Gauvreau
Conditions:
Allergic Asthma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Subjects with allergic asthma developing the required nasal symptoms in response to nasal allergen titration during a screening period will be randomized 1:1 to one of 2 cohorts. All subjects will hav...
Detailed Description
Eligible subjects will be randomized 1:1 to Cohort A or Cohort B. Each cohort will undergo 3 nasal challenges, each separated by 3 weeks. Cohort A will undergo 2 nasal allergen challenges, and 1 nasal...
Eligibility Criteria
Inclusion
- allergic rhinitis + mild asthma
Exclusion
- other respiratory disease
- any medication for treatment of asthma/allergic rhinitis with the exception of infrequent beta-2 agonist.
Key Trial Info
Start Date :
March 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03431961
Start Date
March 7 2018
End Date
February 1 2019
Last Update
August 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardio- Respiratory Research Laboratory, Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N 3Z5